Summary: - General Electric's stock will likely finish the current year down by over 50%. - However, General Electric has several positive catalysts in place that could help propel the stock price higher, which includes the highly anticipated GE Healthcare spin. - I am long GE and I plan to stay long for the foreseeable future (so I am obviously talking my book). 2018 has been an eventful year for General Electric ($GE) and its shareholders, as this storied company will finis

Summary: - Wabash National's stock has not performed well so far in 2018, and I believe that investors should expect for WNC shares to be extremely volatile over the next few quarters. - However, I believe that this shareholder-friendly company is worthy of investment dollars. - I am already long Wabash National, and I may add more WNC shares in the near future. Wabash National ($WNC) pre-announced its Q3 2018 results in early October and the stock fell by over 20%. The stock

Summary: - AT&T's stock has underperformed the broader market over the last 1-, 3-, and 5-year periods. - However, I believe that AT&T will perform well if management is able to show improvements to two key metrics (free cash flow and financial leverage position). - I am long AT&T and I look forward to collecting the rich (and safe) dividend while the company's story plays out in 2019 and beyond. 2018 has been the year of change for AT&T ($T) and, to be honest, I am sure that

Summary: - Accenture reported Q1 2019 results that beat the top- and bottom-line estimates, but management's forward guidance was not well-received by the market. - I believe that the "disappointing" guidance is a short-term headwind that is creating a buying opportunity in a company that has a promising growth profile. - There are several risk factors that need to be considered, but I plan to stay long the stock. Accenture ($ACN) recently reported better-than-expected Q1 201

Summary: - MasTec's stock has significantly underperformed the broader market so far in 2018. - However, I believe that MasTec is well-positioned for 2019 and beyond, with the 5G rollout being a major market opportunity for this small-cap company. - I am long MTZ shares and I may add to my position in the weeks ahead. MasTec's ($MTZ) stock has been under pressure lately, as shown by the fact that MTZ shares are down approximately 25% over the last six months. The stock has al

Summary: - Teladoc Health's stock is down big over the last three months. -And the recent departure of Teladoc Health's Chief Operating Officer/Chief Financial Officer added fuel to the fire. - However, I believe that TDOC shares are still worthy of investment dollars. I am long Teladoc Health and I plan to stay long. Teladoc Health's ($TDOC) stock has faced significant downward pressure as the broader market pulled back over the last few months but, more recently, the high-l

Summary: - MetLife recently held its annual outlook meeting and, in my opinion, the main takeaway from the presentation was that the bull case for this insurer remains intact. - Specifically, MetLife appears to be properly positioned for 2019 and beyond. - I am long MetLife, and I plan to stay long the stock. MetLife's ($MET) stock has fallen out of favor over the last few quarters, which is shown by the fact that its shares are underperforming the broader market by approxima

Summary: - General Electric needs to show some serious progress in its restructuring efforts, but a real turnaround is not going to be easy. - However, I believe that General Electric's management team has levers to pull that should allow them to focus on the top risk factor (i.e., financial leverage). - I am long General Electric and I plan to stay long. 2018 will be a year that General Electric ($GE) and its shareholders will want to forget about. The company's stock starte

Summary: - Charles River Laboratories recently reported Q3 2018 results that beat the top- and bottom-line estimates and management increased their full-year 2018 guidance. - Charles River is well-positioned for 2019, so I believe that this small-cap company is worthy of investment dollars. - I am long CRL shares, and I may get longer in the near future. Charles River Laboratories ($CRL) is a company that does not get much attention, but if you ask me, this will change in the

Summary: Prudential Financial recently held its 2019 investor outlook call. Management guided for the company to have a strong(ish) 2019 and, more importantly, PRU shares are dirt cheap based on several key metrics. I am long Prudential Financial and I may get longer in the near future. Prudential Financial (PRU) recently held its annual investor outlook call and, in my opinion, there was a lot to like about what management had to say. Not only did management project for Prud